These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 34061013)

  • 1. Dihydrotestosterone Induces Chemo-Resistance of Triple-Negative Breast MDA-MB-231 Cancer Cells Towards Doxorubicin Independent of ABCG2 and miR-328-3p.
    Al-Momany B; Hammad H; Ahram M
    Curr Mol Pharmacol; 2021; 14(5):860-870. PubMed ID: 34061013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydrotestosterone regulates expression of CD44 via miR-328-3p in triple-negative breast cancer cells.
    Al-Othman N; Hammad H; Ahram M
    Gene; 2018 Oct; 675():128-135. PubMed ID: 29964098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulating GRP78 reverses pirarubicin resistance of triple negative breast cancer by miR-495-3p mimics and involves the p-AKT/mTOR pathway.
    Liu M; Yang J; Lv W; Wang S; Du T; Zhang K; Wu Y; Feng X
    Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34935899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzalutamide Overcomes Dihydrotestosterone-Induced Chemoresistance in Triple- Negative Breast Cancer Cells
    Alsawalha L; Ahram M; Abdullah MS; Dalmizrak O
    Anticancer Agents Med Chem; 2022; 22(17):3038-3048. PubMed ID: 35579133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumol enhances the sensitivity of doxorubicin in triple-negative breast cancer via regulating the miR-181b-2-3p-ABCC3 axis.
    Zeng C; Fan D; Xu Y; Li X; Yuan J; Yang Q; Zhou X; Lu J; Zhang C; Han J; Gu J; Gao Y; Sun L; Wang S
    Biochem Pharmacol; 2020 Apr; 174():113795. PubMed ID: 31926937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relevance and mechanism of STAT3/miR-221-3p/Fascin-1 axis in EGFR TKI resistance of triple-negative breast cancer.
    Jin LL; Lu HJ; Shao JK; Wang Y; Lu SP; Huang BF; Hu GN; Jin HC; Wang CQ
    Mol Cell Biochem; 2024 Nov; 479(11):3037-3047. PubMed ID: 38145448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acyl-CoA synthetase-4 is implicated in drug resistance in breast cancer cell lines involving the regulation of energy-dependent transporter expression.
    Orlando UD; Castillo AF; Medrano MAR; Solano AR; Maloberti PM; Podesta EJ
    Biochem Pharmacol; 2019 Jan; 159():52-63. PubMed ID: 30414939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiproliferative Effect of Androgen Receptor Inhibition in Mesenchymal Stem-Like Triple-Negative Breast Cancer.
    Zhu A; Li Y; Song W; Xu Y; Yang F; Zhang W; Yin Y; Guan X
    Cell Physiol Biochem; 2016; 38(3):1003-14. PubMed ID: 26938985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of ABCG2 Is Regulated by Its Expression and Localization in DHT and Cyclopamine-Treated Breast Cancer Cells.
    Chua VY; Larma I; Harvey J; Thomas MA; Bentel JM
    J Cell Biochem; 2016 Oct; 117(10):2249-59. PubMed ID: 26917208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
    Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L
    Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GPER mediates decreased chemosensitivity via regulation of ABCG2 expression and localization in tamoxifen-resistant breast cancer cells.
    Yu T; Cheng H; Ding Z; Wang Z; Zhou L; Zhao P; Tan S; Xu X; Huang X; Liu M; Peng M; Qiu YA
    Mol Cell Endocrinol; 2020 Apr; 506():110762. PubMed ID: 32087276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of miR-342-3p on chemotherapy sensitivity in triple-negative breast cancer].
    Ma T; Zhang J; Wu J; Tang J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 May; 39(5):488-95. PubMed ID: 24921394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apigenin by targeting hnRNPA2 sensitizes triple-negative breast cancer spheroids to doxorubicin-induced apoptosis and regulates expression of ABCC4 and ABCG2 drug efflux transporters.
    Sudhakaran M; Parra MR; Stoub H; Gallo KA; Doseff AI
    Biochem Pharmacol; 2020 Dec; 182():114259. PubMed ID: 33011162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-99a-5p modulates doxorubicin resistance via the COX-2/ABCG2 axis in triple-negative breast cancer: from the discovery to in vivo studies.
    Garrido-Cano I; Adam-Artigues A; Lameirinhas A; Blandez JF; Candela-Noguera V; Rojo F; Zazo S; Madoz-Gúrpide J; Lluch A; Bermejo B; Sancenón F; Cejalvo JM; Martínez-Máñez R; Eroles P
    Cancer Commun (Lond); 2022 Dec; 42(12):1412-1416. PubMed ID: 35997029
    [No Abstract]   [Full Text] [Related]  

  • 15. miR-490-3p inhibits the growth and invasiveness in triple-negative breast cancer by repressing the expression of TNKS2.
    Jia Z; Liu Y; Gao Q; Han Y; Zhang G; Xu S; Cheng K; Zou W
    Gene; 2016 Nov; 593(1):41-47. PubMed ID: 27506313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and regulatory function of miRNA-182 in triple-negative breast cancer cells through its targeting of profilin 1.
    Liu H; Wang Y; Li X; Zhang YJ; Li J; Zheng YQ; Liu M; Song X; Li XR
    Tumour Biol; 2013 Jun; 34(3):1713-22. PubMed ID: 23430586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA profiling implies new markers of chemoresistance of triple-negative breast cancer.
    Ouyang M; Li Y; Ye S; Ma J; Lu L; Lv W; Chang G; Li X; Li Q; Wang S; Wang W
    PLoS One; 2014; 9(5):e96228. PubMed ID: 24788655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the breast cancer resistance protein (BCRP/ABCG2) in clear cell renal cell carcinoma.
    Reustle A; Fisel P; Renner O; Büttner F; Winter S; Rausch S; Kruck S; Nies AT; Hennenlotter J; Scharpf M; Fend F; Stenzl A; Bedke J; Schwab M; Schaeffeler E
    Int J Cancer; 2018 Dec; 143(12):3181-3193. PubMed ID: 30070687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin inhibits proteasome activity in triple-negative breast cancer cells through regulating p300/miR-142-3p/PSMB5 axis.
    Liu L; Fu Y; Zheng Y; Ma M; Wang C
    Phytomedicine; 2020 Nov; 78():153312. PubMed ID: 32866906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formononetin relieves the facilitating effect of lncRNA AFAP1-AS1-miR-195/miR-545 axis on progression and chemo-resistance of triple-negative breast cancer.
    Wu J; Xu W; Ma L; Sheng J; Ye M; Chen H; Zhang Y; Wang B; Liao M; Meng T; Zhou Y; Chen H
    Aging (Albany NY); 2021 Jul; 13(14):18191-18222. PubMed ID: 34289449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.